SUMMARY Twenty-seven patients with an isolated brain stem syndrome, thought to be due to demyelination, were examined by magnetic resonance imaging (MRI). A brain stem lesion was identified in 25, and clinically silent lesions outside the brain stem were demonstrated in 20. MRI was more sensitive than evoked potentials in detecting brain stem and other lesions. The scan findings were compared with those in 23 patients with multiple sclerosis, who had chronic brain stem dysfunction, with particular reference to the distribution of abnormalities and the MRI characteristics of the lesions. The relaxation times, T1 and T2, of the lesions were measured by MRI. These values were seen to fall in serial studies of acute lesions, but remained unchanged in the chronic lesions. MRI may therefore allow the age of lesions to be assessed.
Disturbance of brain stem function is frequently found in patients with multiple sclerosis and may be the presenting symptom.' However, it is not known what proportion of patients presenting with an isolated episode of brain stem dysfunction will ultimately prove to have multiple sclerosis. Evoked potentials and x ray computed tomography (CT) have been of limited value in detecting evidence of multiple lesions and examination of the cerebrospinal fluid (CSF) does not consistently show an immunological abnormality in the central nervous system (CNS) of such patients. Since MRI is a sensitive method for detecting plaques in the CNS in patients with known multiple sclerosis,2 we have studied a number of patients presenting with signs of brain stem dysfunction and compared the abnormalities found on MRI with those in patients who have clinically definite multiple sclerosis and a similar brain stem disturbance.
The aim of the study was fourfold. Firstly, to determine the sensitivity of MRI in identifying lesions within the brain stem. Secondly, to compare the sites of the lesions visualised by MRI with the site of damage suggested by neurological and neuro-otological examination. Thirdly, to establish the incidence of clinically unsuspected lesions in parts of the brain other than the brain stem detected by MRI, and to compare these findings with the results of evoked potential studies and the examination of the CSF. Fourthly, to study the natural history of the brain stem lesions with particular reference to the changes in MRI parameters.
Methods

I Subjects
Thirty patients (aged 17 years to 49 years, mean 27-9 years), in whom there was evidence of isolated brain stem dysfunction, were examined. None had a history of neurological dysfunction prior to the development of brain stem symptoms. Subjects aged over 50 years and those with evidence of vascular disease were excluded. In all patients a diagnosis of multiple sclerosis was thought to be possible by the referring neurologist. In addition, 23 patients (aged 24 years to 58 years, mean 36 years) with clinically definite multiple sclerosis were scanned. All had long-standing evidence of brain stem dysfunction. A third group of 50 neurologically normal control subjects (aged 18 years to 60 years, mean 42 years) was also studied. Examinations performed were approved by the Ethics Committee of The National Hospitals, Queen Square and Maida Vale and conformed to the guidelines of The National Radiological Protection Board. 737 stem and in six of these the VEPs were also abnormal. In one patient where the MRI failed to reveal additional, subclinical, abnormalities the VEP was abnormal. In seven patients the CSF was examined and oligoclonal bands were demonstrated in three, all of Ormerod, Bronstein, Rudge et al whom had MRI evidence of cerebral lesions. Normal control subjects Of the 50 subjects in this group, three had abnormalities on MRI; in two there were a small number of discrete lesions within the cerebral white matter; in the third there were widespread lesions indistinguishable from those seen in definite multiple sclerosis. There was nevertheless a highly significant difference (p < 0 001, chi square) between the cerebral MRI changes in patients of groups I and II and the controls. 2 Correlation ofsite ofthe MRI lesion in the brain stem andphysical signsfor groups I and II There was a good correlation between the presence of a VI nerve palsy and the lesion seen on the MRI scan which was either in the floor of the 4th ventricle or deeper in the pons, presumably involving the nucleus of the VI nerve or its fibres respectively (fig 1) . A lesion was seen in one of these sites in all six patients with a VI nerve palsy. Similarly, in all of the eight patients with VII nerve palsies lesions were seen at an appropriate site within the brain stem, including the three with bilateral VII palsies. In the cases with clinical evidence of an isolated VII palsy the MRI lesions were more lateral in the region where the VII nerve fibres pass laterally (fig 2) .
Horizontal gaze palsies were present in three patients and in each case lesions were visualised in an area of the brain stem which could have included the paramedian pontine reticular formation (PPRF), an area thought to be responsible for the generation of saccades.
A combination of these three clinical abnormalities was not infrequently seen. Three patients had combined VI and VII nerve lesions. Another patient had Magnetic resonance imaging in clinically isolated lesions of the brain stem ing from the floor of the IV ventricle into the pons (fig°o In the supra-tentorial cuts changes were again most frequently seen around the ventricles in both the patients with clinically isolated lesions and with clinically definite multiple sclerosis. Periventricular changes were seen in all 23 patients with multiple sclerosis and in 19 of the 27 (70%) patients with clinically isolated brain stem lesions (table 2) . These changes were of similar distribution in these two groups although the abnormalities seen in patients presenting with clinically isolated lesions were less extensive than those seen in patients with established multiple sclerosis (fig 6) .
4 Evolution of the brain stem lesions Contrast in the MR images is multi-parametric and is mainly dependent on the proton density and the relaxation times T1 and T2.5 We therefore reformatted the images to produce computed images of T1 and T2, as observations of intensity alone would not allow the contribution of these parameters to the signal intensity to be assessed. Measurements taken of the brain stem lesions showed that the acute lesions usually had elevated T1 and T2 values relative to those seen in the chronic brain stem lesions (fig 7) , which were in turn higher than those recorded from the normal brain stem in our control group. On follow-up examination the MR characteristics of the acute lesions were seen to fall towards those seen in the chronic lesions (figs 8, 9). T1 and T2 of the chronic lesions showed no significant change over a 3 month period.
Discussion
Until the early 1970s methods of diagnosing multiple sclerosis depended upon the clinical demonstration of two or more lesions in the central nervous system in a patient with symptoms for 1 year or more, in whom there was a relapsing and remitting course and where no other cause was found to account for their disability.6 Since then evoked potential methods have been developed which may demonstrate clinically silent lesions and most neurologists now utilise these methods to assist in the diagnosis of multiple sclerosis. The presence of oligoclonal bands in the CSF is characteristic of multiple sclerosis and some diagnostic classifications7 include these and evoked potential abnormalities in assessing the certainty of the diagnosis. However, neither the evoked potential abnormalities, nor those of the CSF are specific to multiple sclerosis. Imaging of the cerebral hemispheres and brain stem, by conventional CT scanning, has been Ormerod, Bronstein, Rudge et al disappointing in multiple sclerosis even using high dose contrast enhancement in an attempt to localise lesions where the blood brain barrier is defective.8 MRI was first reported to be of value in detecting plaques in the brain in 1981,8 9 an observation which has been confirmed by other groups2 10 and this study.
Of more clinical concern, however, is the patient who presents with an isolated lesion in his first episode. Patients presenting with optic neuritis have a high chance of developing multiple sclerosis during their lifetime and many studies have followed large groups of such patients.11 On the other hand, patients presenting with isolated brain stem lesions have not been followed systematically to determine whether they subsequently develop the disease. The few follow-up data that are available suggest that patients, for example with VI nerve palsies, have a small risk of subsequently developing multiple sclerosis .12 In this study we found a high proportion of our patients have MRI changes in the brain similar to those seen in established multiple sclerosis. It is important to note that our patients were highly selected and cannot be taken as representative of the general population developing isolated cranial nerve palsies, in that they have already been referred to a neurological institute because a neurologist thought the lesion was most likely to be central. This automatically excludes a large number of patients presenting to a general physician with, for example, VI or VII nerve palsies or nystagmus. Be that as it may, in this study evoked potential studies were of limited value in detecting remote lesions in patients presenting acutely although rather better in those who have had their disorder for a number of years. CSF examination was abnormal in a higher proportion of acute lesions but the presence of oligoclonal bands is not specific to multiple sclerosis. In contrast to this, MRI detected multiple lesions in the brain in over 70% of patients and demonstrated the lesion in the brain stem in all but three cases. The question arises as to the specificity of these lesions. Although lesions of similar appearance can be seen in patients with vascular disease, especially over the age of 50 years,13 we tentatively suggest that in the present study multiple sclerosis is the most likely diagnosis. In comparing the scans of the patients with clinically isolated brain stem lesions and those with established multiple sclerosis there are striking similarities. In particular the periventricular lesions which are so characteristic of the disease from pathological studies"4 were seen in both groups of patients, the occipital horns and trigones being most frequently involved. Similarly, the discrete white matter lesions were indistinguishable. These findings support the Magnetic resonance imaging in clinically isolated lesions of the brain stem concept that many of the patients with apparently isolated lesions have multiple sclerosis. Proof must await long term follow-up.
If, as seems probable, an estimate of the age of lesions can be made from their T1 and T2 characteristics, it may be possible to determine the time-course of the cerebral and brain stem abnormalities, and determine whether all lesions are accrued simultaneously in a patient. The origin of the increased T1 and T2 of the lesions is not fully established. Oedema probably contributes in the acute phase and resolution of oedema and inflammation is the presumed mechanism of the fall in T1 and T2 to values seen in chronic lesions where replacement of myelin by glial fibres is the most prominent histological change. There is evidence that the protons of myelin do not contribute to the signal obtained from normal brain"314 and the MR characteristics of chronic lesions are thought to be due to an increase in water, compared with normal white matter, and an altered physicochemical environment.
The prognostic implications of the cerebral abnormalities seen in patients with isolated lesions are not, as yet, determined and it is not possible to make a diagnosis of multiple sclerosis on the basis of disseminated lesions on MRI in a patient with a single clinical episode. If multiple lesions of different ages were demonstrated in a patient there would be grounds for assuming that the neurological illness was not monophasic. Such a finding would suggest a disease which was still active and in which lesions were accumulated over a longer period of time, a process known to occur in multiple sclerosis. The diagnosis of multiple sclerosis remains essentially clinical and demyelinating lesions within the CNS without clinical sequelae are not sufficient grounds on which to base the diagnosis. Long term follow-up relating MRI changes to eventual clinical outcome will reveal the significance of such abnormalities. Our results are part of a prospective study which we hope will resolve these unanswered problems.
